Results
Medicamen Biotech Reports ₹9.8 Crore PAT, Declares Dividend
Medicamen Biotech reported consolidated net profit of ₹9.8 crore for FY26 with 21.7% revenue growth to ₹197.8 crore and declared a final dividend of ₹1 per share.
The company completed preferential al
